DOAC + NSAID/antiplatelet — bleeding
- Pharmacodynamic bleeding interaction
- DOAC impairs coagulation
- NSAID/antiplatelet impairs hemostasis
- GI bleeding risk especially increases
- Avoid chronic combo unless indicated
- Use gastroprotection when appropriate
Interaction at a glance
- Pharmacodynamic bleeding interaction
- DOAC impairs coagulation
- NSAID/antiplatelet impairs hemostasis
- Avoid chronic combo unless indicated
Clinical consequence
- Pharmacodynamic bleeding interaction
- DOAC impairs coagulation
- NSAID/antiplatelet impairs hemostasis
Who is at greatest risk
- GI bleeding risk especially increases
Management
- Avoid chronic combo unless indicated
- Use gastroprotection when appropriate
Self-check
- What is the main clinical risk of DOAC + NSAID/antiplatelet?
Pharmacodynamic bleeding interaction.
- What is the preferred management of DOAC + NSAID/antiplatelet?
Avoid chronic combo unless indicated.
Drugs in this interaction (32)
All interaction examples · Open the interactive console ↗